Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance.

Mod Rheumatol 2018 Jan 27;28(1):101-107. Epub 2017 Apr 27.

d Fuji Toranomon Orthopedics Hospital , Shizuoka , Japan.

Objectives: The objectives of this surveillance were to determine safety and effectiveness of etanercept in patients with juvenile idiopathic arthritis (JIA).

Methods: In this postmarketing surveillance, patients aged 5-16 years with active polyarthritis JIA were treated with etanercept at the doses approved in the Japanese package insert. The occurrence and seriousness of adverse events (AEs) were assessed using the Japanese Medical Dictionary for Regulatory Activities version 15.1. Effectiveness was determined as the improvement from baseline in disease activity score in 28 joints (DAS28)-erythrocyte sedimentation rate (ESR), remission, and physician's assessment of overall improvement. The number of responders was expressed as a percentage. The last observation carried forward method was used to impute missing data.

Results: Safety analysis included 102 patients; 22 patients experienced 36 treatment-related AEs, three of which were unexpected. None of the AEs were deemed to need special safety warnings. Effectiveness analysis included 87 patients. At 24 weeks, 29/46 (63.0%) patients demonstrated either good or moderate response in DAS28-4/ESR and treatment was assessed to be markedly effective or effective by physicians in 79/83 (95.2%) patients.

Conclusions: These data are consistent with earlier reports showing that etanercept was effective and demonstrated no safety signals in patients with JIA.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14397595.2017.1310704DOI Listing
January 2018
99 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: Blssfulserndpty
December 30, 2017, 6:51 pm EST
twitter
Twitter: Blssfulserndpty
December 20, 2017, 3:19 pm EST
twitter
Twitter: Meed_ref
May 3, 2017, 7:33 am EST

Publication Analysis

Top Keywords

analysis included
8
idiopathic arthritis
8
juvenile idiopathic
8
effectiveness etanercept
8
postmarketing surveillance
8
safety effectiveness
8
patients
7
safety
5
missing dataresults
4
dataresults safety
4
method impute
4
observation carried
4
carried forward
4
forward method
4
impute missing
4
included 102
4
treatment-related aes
4
aes three
4
three unexpected
4
experienced treatment-related
4

References

(Supplied by CrossRef)
Article in J Rheumatol
Feldman BM et al.
J Rheumatol 2000

Similar Publications